Levocetirizine dihydrochloride tablet and minolast -10 is used for
Reading File
Searching the Web
Levocetirizine dihydrochloride Montelukast Minolast-10 uses indications
Finding Sources
Here is a complete breakdown of what Levocetirizine Dihydrochloride and Minolast-10 (Montelukast 10 mg) are used for - individually and as a combination:
Levocetirizine Dihydrochloride (5 mg)
Levocetirizine is a second-generation antihistamine (H1 receptor blocker). It works by blocking the effects of histamine, the chemical released during allergic reactions.
Uses:
- Allergic Rhinitis (seasonal/hay fever and perennial/year-round) - relieves sneezing, runny nose, itchy/watery eyes, nasal congestion
- Chronic Urticaria (chronic hives) - reduces itching and skin welts
- Allergic conjunctivitis (itchy, watery eyes)
- Skin allergies and allergic dermatitis
Key features:
- Works fast - usually within 1 hour
- Less sedating than older antihistamines (e.g., chlorphenamine)
- Taken once daily, usually in the evening
Minolast-10 (Montelukast 10 mg)
Montelukast is a leukotriene receptor antagonist (LTRA). It blocks leukotrienes - inflammatory chemicals that cause airway narrowing, mucus production, and allergy symptoms.
Uses:
- Allergic Rhinitis (seasonal and perennial) - reduces nasal symptoms and inflammation
- Asthma (prophylaxis and long-term control) - prevents asthma symptoms, especially allergic/atopic asthma
- Exercise-induced bronchoconstriction - taken before exercise to prevent airway narrowing
- Comorbid asthma + allergic rhinitis - particularly effective when both conditions coexist
Key features:
- Does NOT treat acute asthma attacks
- Takes a few days to show full effect
- Given once daily at night (10 mg for adults and adolescents 15+)
Why They Are Combined (Levocetirizine + Montelukast)
These two drugs target different pathways of the allergic response, making them highly complementary:
| Feature | Levocetirizine | Montelukast |
|---|---|---|
| Drug class | Antihistamine (H1 blocker) | Leukotriene receptor antagonist |
| Target | Histamine | Leukotrienes (LTC4, LTD4, LTE4) |
| Main use | Sneezing, runny nose, itchy eyes | Airway inflammation, asthma |
| Onset | Rapid | Gradual (days) |
Combination indications:
- Seasonal and perennial allergic rhinitis - provides broader symptom control than either drug alone
- Allergic rhinitis with comorbid asthma - the most common reason for this combination
- Chronic urticaria with respiratory allergy
- Patients who do not respond adequately to antihistamine alone
Important Warnings
- Montelukast carries an FDA black box warning for neuropsychiatric events: agitation, aggression, anxiety, depression, suicidal thoughts, hallucinations, and sleep disturbances. Patients and caregivers should be alerted.
- Levocetirizine can cause drowsiness/somnolence - avoid driving if affected.
- Both should be used cautiously in patients with severe kidney disease.
- Not for acute asthma attacks (use a bronchodilator like salbutamol instead).
In short: This tablet combination is prescribed primarily for allergic rhinitis (with or without asthma), offering dual-pathway blockade of the allergic response - histamine via levocetirizine and leukotrienes via montelukast.
This is a shared conversation. Sign in to Orris to start your own chat.